RESTORIL (TEMAZEPAM) — FDA Approval NDA018163 (SPECGX LLC)
RESTORIL (TEMAZEPAM) — FDA Approval NDA018163 (SPECGX LLC) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: RESTORIL; Active ingredients: TEMAZEPAM; Application number: NDA018163.
| Brand name | RESTORIL |
|---|---|
| Active ingredients | TEMAZEPAM |
| Application number | NDA018163 |
| Sponsor | SPECGX LLC |
| Dosage form | CAPSULE |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 4 |
| First approval date | 19810227 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →